|
|
Micro-randomized trial of a physical activity intervention to manage pain symptoms among older cancer survivors |
| 1K01CA255414-01A1 |
|
NCI |
2022 |
|
|
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
| 5R01CA237892-03 |
|
NCI |
2022 |
|
|
Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs |
| 1R15AI156879-01A1 |
|
NIAID |
2022 |
|
|
I-Corps: Optical design and the development of high accuracy automated tick classification using computer vision |
| 3R43AI162425-01A1S1 |
|
NIAID |
2022 |
|
|
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica |
| 5R01AI130548-05 |
|
NIAID |
2022 |
|
|
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis |
| 5R01AI143676-03 |
|
NIAID |
2022 |
|
|
Molecular Mechanisms of IL-17-dependent autoimmune signaling |
| 5R01AI147383-03 |
|
NIAID |
2022 |
|
|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
| 5R01AI148178-03 |
|
NIAID |
2022 |
|
|
Development of A HTLV-1 Vaccine |
| 1 R01 CA252049-01A1 |
BARBER, GLEN N |
NCI |
2021 |
|
|
Therapeutic potential of targeting DNA repair deficiency in TSC |
| 1 R21 CA263133-01 |
|
NCI |
2021 |